OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice
Jonathan M. Weiss, Erika M. Palmieri, Marieli Gonzalez-Cotto, et al.
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 981-995
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis
Chao Chen, Zhenxing Zhang, Caiyun Liu, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 498-510.e11
Closed Access | Times Cited: 27

The IRG1–itaconate axis protects from cholesterol-induced inflammation and atherosclerosis
Yannick Cyr, Fazli Bozal, José Gabriel Barcia Durán, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 20

Itaconate in host inflammation and defense
Dan Ye, Pu Wang, Leilei Chen, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 586-606
Closed Access | Times Cited: 16

4-Octyl itaconate restricts STING activation by blocking its palmitoylation
Chaofei Su, Tian‐Lu Cheng, Jian Huang, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113040-113040
Open Access | Times Cited: 37

Metabolic Messengers: itaconate
Anne F. McGettrick, L. A. Bourner, Frank C. Dorsey, et al.
Nature Metabolism (2024) Vol. 6, Iss. 9, pp. 1661-1667
Closed Access | Times Cited: 11

Integration of cross-correlation analysis and untargeted flavoromics reveals unique flavor formation of lactic acid bacteria co-fermented oat beverage
Qian Yu, Jiaqin Qian, Qinwei Xu, et al.
Food Bioscience (2024) Vol. 59, pp. 103855-103855
Closed Access | Times Cited: 8

Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming
Erika M. Palmieri, Ronald Holewinski, Christopher McGinity, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21

Itaconate uptake via SLC13A3 improves hepatic antibacterial innate immunity
Chao Chen, Caiyun Liu, Pengkai Sun, et al.
Developmental Cell (2024) Vol. 59, Iss. 21, pp. 2807-2817.e8
Closed Access | Times Cited: 6

Itaconate alleviates diet-induced obesity via activation of brown adipocyte thermogenesis
Zihan Yu, Xianju Li, Yanni Quan, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114142-114142
Open Access | Times Cited: 5

Inflammaging and fatty acid oxidation in monocytes and macrophages
Victor Kruglov, In Hwa Jang, Christina Camell
Immunometabolism (2024) Vol. 6, Iss. 1, pp. e00038-e00038
Open Access | Times Cited: 4

ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota
Tanja Eberhart, Federico Uchenna Stanley, Luisa Ricci, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4

Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 4

In vivo itaconate tracing reveals degradation pathway and turnover kinetics
Hanna Friederike Willenbockel, Alexander T. Williams, Alfredo Lucas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Hypoxia-inducible factor-1α inhibitor promotes non-alcoholic steatohepatitis development and increases hepatocellular lipid accumulation via TSKU upregulation
Renli Zeng, Yuxin Wang, Jielu Wen, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110313-110313
Closed Access

Dissecting S-itaconation at host–pathogen interactions with chemical proteomics tools
Zihua Liu, Chu Wang
Current Opinion in Microbiology (2025) Vol. 83, pp. 102579-102579
Closed Access

Effects of natural products on macrophage immunometabolism: a new frontier in the treatment of metabolic diseases
Jiani Li, Guo Chen, Xiaofei Yang, et al.
Pharmacological Research (2025), pp. 107634-107634
Open Access

Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy
Xiaodong Wu, Yanhong Song, Zhengwei Yuan, et al.
Metabolism (2025), pp. 156152-156152
Closed Access

Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis
Linjing Long, Yue Wu, Huijun Tang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Insights into the itaconate family: immunomodulatory mechanisms and therapeutic potentials
Chunlin Qian, Yueying Wang, Quan Yuan, et al.
European Journal of Pharmacology (2025), pp. 177542-177542
Closed Access

Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler, Leona Sophia Prammer, Gerwin Heller, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-224898
Open Access | Times Cited: 3

Effects of triglyceride and ethyl ester forms of EPA on hepatic lipid metabolism in mice with non-alcoholic fatty liver disease
Junli Feng, Shitong Wang, Feifei Chen, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106179-106179
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top